Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Illumina has acquired Fluent BioSciences, enhancing its single-cell analysis and multiomics capabilities. Fluent's innovative technology, including the PIPseq V system, offers cost-effective and scalable solutions, strengthening Illumina's market position and growth strategy.